Skip to main content
Clinical Trials/NCT03393260
NCT03393260
Completed
N/A

Epidemiological Characteristics and Prognosis Factors of Cancer Patients Admitted at French Emergency Departments

Assistance Publique - Hôpitaux de Paris1 site in 1 country1,380 target enrollmentFebruary 6, 2018

Overview

Phase
N/A
Intervention
Not specified
Conditions
Cancer Patients
Sponsor
Assistance Publique - Hôpitaux de Paris
Enrollment
1380
Locations
1
Primary Endpoint
Reasons for cancer patients to seek care in EDs
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

Patients with cancer or hematological malignancy are susceptible to present acute complications linked to their disease or to their specific treatments (dyspnea, sepsis, coma, hemorrhagic syndrome). Emergency physicians are in first line when these complications arise and have to face with some complex situations in which informations about patient malignancy or prognosis may be lacking. Nowadays, there is very few epidemiological data published concerning how cancer patient use Emergency Departments (EDs) and cancer patient care delivery in the EDs.

Thus, an observational multicenter prospective cross-sectional study is conducted to study the prevalence of cancer patients admitted to French EDs, and to describe the different reasons for cancer patients to seek care in EDs with their prevalence and underscore those linked to cancer or treatment complication

Registry
clinicaltrials.gov
Start Date
February 6, 2018
End Date
October 31, 2019
Last Updated
6 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • adult patients (age \>=18 years)
  • with active malignancy or a history of cancer in remission within the last 5 years
  • being attended in one of the 400 French emergency centers participating in the study during the 3-day study period

Exclusion Criteria

  • opposition to participate

Outcomes

Primary Outcomes

Reasons for cancer patients to seek care in EDs

Time Frame: 1 day

Secondary Outcomes

  • ICU mortality(7 days)
  • cancer location(1 day)
  • hospitalisation rate(1 day)
  • intensive care unit (ICU) admission(7 days)

Study Sites (1)

Loading locations...

Similar Trials